ArticleBlood advances2025

Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma.

Arghya Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.